Actively Recruiting
Database and Biobank of Patients With Hypersensitivity Pneumonitis
Led by Nils Hoyer · Updated on 2023-12-22
50
Participants Needed
1
Research Sites
328 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Sub-study of the main Pulmonary Fibrosis Biomarker (PFBIO) cohort (NCT02755441), recruiting patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP). Patients are included for the collection of blood samples and regular clinical data. The database and biobank will be available for studies of HP, and can be directly compared to the main PFBIO cohort, which has recruited patients with Idiopathic pulmonary Fibrosis (IPF) since 2016. Biomarkers will be assessed as diagnostic and prognostic. Further subtyping of HP, based on blood markers (including precipitins) will also be possible with the PFBIO-HP project.
CONDITIONS
Official Title
Database and Biobank of Patients With Hypersensitivity Pneumonitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of HP at an MDT conference according to the current international guidelines
- Age of 18 years or older
- The patients must be capable of giving informed consent
You will not qualify if you...
- Unable to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of respiratory medicine
Hellerup, Copenhagen, Denmark, 2900
Actively Recruiting
Research Team
N
Nils Hoyer, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here